The Drude-Smith model has been used extensively in fitting the THz conductivities of nanomaterials with carrier confinement on the mesoscopic scale. Here, we show that the conventional 'backscattering' explanation for the suppression of low-frequency conductivities in the Drude-Smith model is not consistent with a confined Drude gas of classical non-interacting electrons and we derive a modified Drude-Smith conductivity formula based on a diffusive restoring current. We perform Monte Carlo simulations of a model system and show that the modified Drude-Smith model reproduces the extracted conductivities without free parameters. This alternate route to the DrudeSmith model provides the popular formula with a more solid physical foundation and well-defined fit parameters.
The magnetic fields of linac-MR systems modify the path of contaminant electrons in photon beams, which alters patient entrance skin dose. Also, the increased SSD of linac-MR systems reduces the maximum achievable dose rate. To accurately quantify the changes in entrance skin dose, the authors use EGSnrc Monte Carlo calculations that incorporate 3D magnetic field of the Alberta 0.5 T longitudinal linac-MR system. The Varian 600C linac head geometry assembled on the MRI components is used in the BEAMnrc simulations for 6 MV and 10 MV beam models and skin doses are calculated at an average depth of 70 μm using DOSXYZnrc. 3D modeling shows that magnetic fringe fields decay rapidly and are small at the linac head. SSDs between 100 and 120 cm result in skin-dose increases of between ~6%-19% and ~1%-9% for the 6 and 10 MV beams, respectively. For 6 MV, skin dose increases from ~10.5% to ~1.5% for field-size increases of 5 × 5 cm(2) to 20 × 20 cm(2). For 10 MV, skin dose increases by ~6% for a 5 × 5 cm(2) field, and decreases by ~1.5% for a 20 × 20 cm(2) field. Furthermore, the proposed reshaped flattening filter increases the dose rate from the current 355 MU min(-1) to 529 MU min(-1) (6 MV) or 604 MU min(-1) (10 MV), while the skin-dose increases by only an additional ~2.6% (all percent increases in skin dose are relative to D max). This study suggests that there is minimal increase in the entrance skin dose and minimal/no decrease in the dose rate of the Alberta longitudinal linac-MR system. The even lower skin dose increase at 10 MV offers further advantages in future designs of linac-MR prototypes.
The authors have successfully designed and simulated an S-band waveguide of length of 27.5 cm capable of producing a 10 MV photon beam. This waveguide operates well within the breakdown threshold determined for the cavity geometry used. The designed Linac produces depth dose profiles similar to those of the emulated 10 MV Linac (waveguide-length of 1.5 m) but yields a narrower penumbra.
We adapt a variational procedure to calculate ground-state properties of the Holstein model in the adiabatic limit. At strong coupling, this adaption leads to rapid convergence of results. The intermediate coupling regime is further handled with an adaptive algorithm. We also use semiclassically derived results for the adiabatic end point, along with weak coupling perturbation theory. These establish weak and strong coupling ͑or large and small polaron, respectively͒ regimes in two dimensions or higher. As is well known, these are connected smoothly, but the crossover becomes increasingly abrupt as the phonon frequency decreases.
The authors' simulation results show that a short, high-energy, s-band accelerator is feasible and electric breakdown is not expected to interfere with operation at these field strengths. With minor modifications to the first coupling cavity, all electron beam parameters are improved.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.